These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Expression of Mcm-2, Ki-67 and geminin in benign and malignant salivary gland tumours. Vargas PA; Cheng Y; Barrett AW; Craig GT; Speight PM J Oral Pathol Med; 2008 May; 37(5):309-18. PubMed ID: 18248354 [TBL] [Abstract][Full Text] [Related]
8. Expression of KIT (CD117) in neoplasms of the head and neck: an ancillary marker for adenoid cystic carcinoma. Mino M; Pilch BZ; Faquin WC Mod Pathol; 2003 Dec; 16(12):1224-31. PubMed ID: 14681323 [TBL] [Abstract][Full Text] [Related]
9. The PRKD1 E710D hotspot mutation is highly specific in separating polymorphous adenocarcinoma of the palate from adenoid cystic carcinoma and pleomorphic adenoma on FNA. Andreasen S; Melchior LC; Kiss K; Bishop JA; Høgdall E; Grauslund M; Wessel I; Homøe P; Agander TK Cancer Cytopathol; 2018 Apr; 126(4):275-281. PubMed ID: 29266837 [TBL] [Abstract][Full Text] [Related]
10. The adhesion molecules NCAM, HCAM, PECAM-1 and ICAM-1 in normal salivary gland tissues and salivary gland malignancies. Perschbacher K; Jackson-Boeters L; Daley T J Oral Pathol Med; 2004 Apr; 33(4):230-6. PubMed ID: 15061711 [TBL] [Abstract][Full Text] [Related]
12. Wnt/β-catenin signal alteration and its diagnostic utility in basal cell adenoma and histologically similar tumors of the salivary gland. Sato M; Yamamoto H; Hatanaka Y; Nishijima T; Jiromaru R; Yasumatsu R; Taguchi K; Masuda M; Nakagawa T; Oda Y Pathol Res Pract; 2018 Apr; 214(4):586-592. PubMed ID: 29496310 [TBL] [Abstract][Full Text] [Related]
13. Abnormal activation of the Akt signaling pathway in adenoid cystic carcinoma. Branco KFCC; Ribeiro ALR; de Mendonça RP; de Jesus Viana Pinheiro J; da Silva Kataoka MS; Arnaud MVC; de Melo Alves Junior S Eur Arch Otorhinolaryngol; 2018 Dec; 275(12):3039-3047. PubMed ID: 30367261 [TBL] [Abstract][Full Text] [Related]
14. p63 expression in salivary gland tumors: role of DeltaNp73L in neoplastic transformation. Foschini MP; Gaiba A; Cocchi R; Pennesi MG; Pession A Int J Surg Pathol; 2005 Oct; 13(4):329-35. PubMed ID: 16273188 [TBL] [Abstract][Full Text] [Related]
15. Expression patterns and prognostic significance of inhibitor of apoptosis proteins in adenoid cystic carcinoma and pleomorphic adenoma of lachrymal gland. Liao Y; Zeng H; Wang X; Huang Y; Chen N; Ge B; Tang L; Luo Q Exp Eye Res; 2009 Jan; 88(1):4-11. PubMed ID: 18955046 [TBL] [Abstract][Full Text] [Related]
16. Differential expression of galectin-3, beta-catenin, and cyclin D1 in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma of salivary glands. Ferrazzo KL; Neto MM; dos Santos E; dos Santos Pinto D; de Sousa SO J Oral Pathol Med; 2009 Oct; 38(9):701-7. PubMed ID: 19659475 [TBL] [Abstract][Full Text] [Related]
17. CD24 and CD44 in salivary gland pleomorphic adenoma and in human salivary gland morphogenesis: differential markers of glandular structure or stem cell indicators? Ianez RC; Coutinho-Camillo CM; Buim ME; Pinto CA; Soares FA; Lourenço SV Histopathology; 2013 Jun; 62(7):1075-82. PubMed ID: 23600676 [TBL] [Abstract][Full Text] [Related]
18. Glycosaminoglycans in pleomorphic adenoma and adenoid cystic carcinoma of the salivary gland. Nakanishi K; Kawai T; Suzuki M; Shinmei M Arch Pathol Lab Med; 1990 Dec; 114(12):1227-31. PubMed ID: 2174671 [TBL] [Abstract][Full Text] [Related]
19. Pleomorphic adenoma and adenoid cystic carcinoma of salivary glands: E-cadherin immunoexpression and analysis of the CDH1 -160C/A polymorphism. Cavalcante RB; Nonaka CF; Rabenhorst SH; da Costa Miguel MC; Pinto LP; de Souza LB Arch Oral Biol; 2017 Jan; 73():48-54. PubMed ID: 27665273 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical features of lacrimal gland epithelial tumors. Mendoza PR; Jakobiec FA; Krane JF Am J Ophthalmol; 2013 Dec; 156(6):1147-1158.e1. PubMed ID: 23972314 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]